With 18.5 million Americans struggling with substance use disorders, also known as addiction, there is no question that the USA has a drug epidemic. Today, overdoses, drug and alcohol related deaths, and drug and alcohol related hospitalizations are higher than they’ve ever been. Micro dosing using psychedelics is one proposed solution, and one that has gained significant traction over the last 60 years. In fact, microdosing to avoid alcohol or heroin has been used as far back as the 1960s, where artists like Jimi Hendrix famously failed to make it work.
Today, it’s been popularized by the media, by groups like the Psychedelics in Recovery (PiR) group, and by people looking for an easy way out of drug and alcohol use disorder.
Microdosing is the concept of taking a tiny dose of a substance, usually a psychedelic. This psychedelic can be LSD, psylocibin, MDMA, and others. The point is that it is taken at such a tiny dose as to have very small or even no noticeable effects and to use that to maintain a long-term habit. Supposedly, this drug habit, can help users to move away from cravings, to experiencing life, to finding joy in life without drugs or alcohol.
That’s also been researched by multiple very serious medical organizations. For example, the John Hopkins Center for Psychedelics and Consciousness Research has led multiple studies to that effect. For example, in one such study, 15 people underwent 3-6 weeks of CBT with three doses of psilocybin. At 6 months, a blood and urine analysis showed that 80% had been abstinent at least 7 days before the blood test. This was indicative of long-term recovery but as patients were informed of the upcoming blood test, the trial results are not as valid as from a random controlled test. At a second, 12-month follow-up, 60% had been clean for at least the previous 7 days.
That’s significantly higher than the average 35% success rate of using Cognitive behavioral therapy to treat smoking use disorder. However, with the small sample size of just 15 persons and the limited follow-up with warning to the individuals being tested, the study is of little validity.
MDMA is also proposed as a treatment method for alcohol use disorder. However, this study proposes MDMA as a therapy treatment, helping alcoholics to open up and share about experiences and trauma – rather than as a “cure” for cravings and addiction. Here, MDMA-assisted psychotherapy is proposed to help alcoholics to deal with trauma in ways that they could not while entirely sober.
Psychedelics are drugs which have often severe impacts on the mind and body. Most psychedelic medications impact the serotonin receptors in the brain, resulting in changes in how the body regulates, in changes to sleep, in changes to emotions, and in changes to the reward circuit. In fact, many hallucinogens take effect because they mimic the effects of serotonin. This can cause significant reduction in serotonin production inside the brain – resulting in the same emotional blunting and “down” periods experienced by heavy alcohol or amphetamine abusers. Over the long-term, daily users risk periods of withdrawal and struggling to experience full emotion following cessation of psychedelics. That’s without considering the switch from the “high” emotional output of being on those drugs to the “normal” emotions of being off them. So, someone quitting a psychedelic used as maintenance therapy is very likely to feel bad or to feel apathetic, which could lead to relapse.
Psychedelics are also far from safe for many users. In fact, even during the study by John Hopkins Medical Center, a significant portion of participants experienced high anxiety. Individuals with schizophrenia, bipolar disorder, and borderline personality disorder are especially sensitive to this. Taking a hallucinogenic could greatly exacerbate issues, cause anxiety, and kick-off manic or psychotic episodes.
Proponents argue that it’s possible to fully screen candidates and to give out psychedelics in a medical setting. However, many of the people using psychedelics to microdose are doing so outside of clinical settings. Most never see a doctor. Instead, they hear advice on the internet and follow up on it, often with the help of friends or a local group into the practice. This results in a high risk of poor screening and a high risk of poor side effects. Individuals with risk factors for anxiety can experience negative anxiety highs for months following a single dose.
One of the largest proponents against microdosing to “cure” substance use disorder is that there is no cure. Addicts have a history of chasing the next thing that will make them feel better. Chasing a psychedelic or microdosing strategy feels much like a continuation of the same process. People who don’t stop to change habits or build better coping mechanisms will always be at the whim of a drug that makes them feel better. So, even if psychedelics do aid in cessation for some users, they cover the symptoms and not the problem.
Essentially, if you’re using microdosing to cover the symptoms of cravings, withdrawal, or a need for added stimulus in your life, you’re at the mercy of those drugs as soon as that microdosing stops being enough. That’s important, considering people build up tolerance to psychedelics in the same way they do to other drugs. In order to maintain the same effects, you have to increase dosage over time, eventually resulting in physical dependency. While the addiction profile for most psychedelics is very low, the risk is still there. More importantly, without having sought out rehab and addiction treatment for an existing addiction, chances are, you’ll turn back to your drug of choice when the microdosing stops being enough.
In conclusion, psychedelics may have some impact on how people experience and take drugs. They may have some impact on cravings. And they may have some impact on therapy and how it is perceived. However, it is important to only ever seek out medical treatment of this kind in a medical setting. People receiving microdosing must be screened to ensure they can do so without risking crippling anxiety. And, they must take on cognitive behavioral therapy and other measures to correct underlying behavioral and emotional problems. Otherwise, you risk relapsing, after tolerance has gone down. Psychedelics are a drug like any other drug and they should not be started lightly. If you find yourself thinking you can take them and keep everything under control, that might very well be the addict behaviors talking. And that’s important to recognize, acknowledge, and deal with before looking for cures or easy ways out.
© Copyright 2024 Asana Recovery™
| All Rights Reserved | Privacy Policy
Asana Recovery | Headquarters | 1730 Pomona Ave Suite 3, Costa Mesa, CA 92627, United States
Asana Recovery
We firmly believe that the internet should be available and accessible to anyone, and are committed to providing a website that is accessible to the widest possible audience, regardless of circumstance and ability.
To fulfill this, we aim to adhere as strictly as possible to the World Wide Web Consortium’s (W3C) Web Content Accessibility Guidelines 2.1 (WCAG 2.1) at the AA level. These guidelines explain how to make web content accessible to people with a wide array of disabilities. Complying with those guidelines helps us ensure that the website is accessible to all people: blind people, people with motor impairments, visual impairment, cognitive disabilities, and more.
This website utilizes various technologies that are meant to make it as accessible as possible at all times. We utilize an accessibility interface that allows persons with specific disabilities to adjust the website’s UI (user interface) and design it to their personal needs.
Additionally, the website utilizes an AI-based application that runs in the background and optimizes its accessibility level constantly. This application remediates the website’s HTML, adapts Its functionality and behavior for screen-readers used by the blind users, and for keyboard functions used by individuals with motor impairments.
If you’ve found a malfunction or have ideas for improvement, we’ll be happy to hear from you. You can reach out to the website’s operators by using the following email
Our website implements the ARIA attributes (Accessible Rich Internet Applications) technique, alongside various different behavioral changes, to ensure blind users visiting with screen-readers are able to read, comprehend, and enjoy the website’s functions. As soon as a user with a screen-reader enters your site, they immediately receive a prompt to enter the Screen-Reader Profile so they can browse and operate your site effectively. Here’s how our website covers some of the most important screen-reader requirements, alongside console screenshots of code examples:
Screen-reader optimization: we run a background process that learns the website’s components from top to bottom, to ensure ongoing compliance even when updating the website. In this process, we provide screen-readers with meaningful data using the ARIA set of attributes. For example, we provide accurate form labels; descriptions for actionable icons (social media icons, search icons, cart icons, etc.); validation guidance for form inputs; element roles such as buttons, menus, modal dialogues (popups), and others. Additionally, the background process scans all the website’s images and provides an accurate and meaningful image-object-recognition-based description as an ALT (alternate text) tag for images that are not described. It will also extract texts that are embedded within the image, using an OCR (optical character recognition) technology. To turn on screen-reader adjustments at any time, users need only to press the Alt+1 keyboard combination. Screen-reader users also get automatic announcements to turn the Screen-reader mode on as soon as they enter the website.
These adjustments are compatible with all popular screen readers, including JAWS and NVDA.
Keyboard navigation optimization: The background process also adjusts the website’s HTML, and adds various behaviors using JavaScript code to make the website operable by the keyboard. This includes the ability to navigate the website using the Tab and Shift+Tab keys, operate dropdowns with the arrow keys, close them with Esc, trigger buttons and links using the Enter key, navigate between radio and checkbox elements using the arrow keys, and fill them in with the Spacebar or Enter key.Additionally, keyboard users will find quick-navigation and content-skip menus, available at any time by clicking Alt+1, or as the first elements of the site while navigating with the keyboard. The background process also handles triggered popups by moving the keyboard focus towards them as soon as they appear, and not allow the focus drift outside it.
Users can also use shortcuts such as “M” (menus), “H” (headings), “F” (forms), “B” (buttons), and “G” (graphics) to jump to specific elements.
We aim to support the widest array of browsers and assistive technologies as possible, so our users can choose the best fitting tools for them, with as few limitations as possible. Therefore, we have worked very hard to be able to support all major systems that comprise over 95% of the user market share including Google Chrome, Mozilla Firefox, Apple Safari, Opera and Microsoft Edge, JAWS and NVDA (screen readers).
Despite our very best efforts to allow anybody to adjust the website to their needs. There may still be pages or sections that are not fully accessible, are in the process of becoming accessible, or are lacking an adequate technological solution to make them accessible. Still, we are continually improving our accessibility, adding, updating and improving its options and features, and developing and adopting new technologies. All this is meant to reach the optimal level of accessibility, following technological advancements. For any assistance, please reach out to